Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 25, 2013 - Issue 11
250
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA

, , , , &
Pages 1470-1476 | Received 11 Oct 2012, Accepted 05 Feb 2013, Published online: 21 Mar 2013

References

  • AIDS Education & Training Centers National Resource Center. (2011). HIV classification: CDC and WHO staging systems. Retrieved from http://www.aids-ed.org/aidsetc?page=cg-205_hiv_classification
  • Cain, L. E., Logan, R., Robins, J. M., Sterne, J. A., Sabin, C., Bansi, L., … Hernan, M. A. (2011). When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: An observational study. Annual International Medicine, 154(8), 509–515.
  • Centricity© Clinical Data Services (CDS). (2008). Database manual. Barrington, IL: GE Healthcare, General Electric Co.
  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. doi:10.1056/NEJMoa1105243
  • Giacovelli, J. K., Egorova, N., Nowygrod, R., Gelijns, A., Kent, K. C., & Morrissey, N. J. (2008). Insurance status predicts access to care and outcomes of vascular disease. Journal of Vascular Surgery, 48(4), 905–911. doi:10.1016/j.jvs.2008.05.010
  • Kahn, J. G., Zhang, X., Cross, L. T., Palacio, H., Birkhead, G. S., & Morin, S. F. (2002). Access to and use of HIV antiretroviral therapy: Variation by race/ethnicity in two public insurance programs in the U.S. Public Health Reports, 117(3), 252–262. discussion 231–252. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1497435/
  • Kates, J. (2011). Medicaid and HIV: A National Analysis. Menlo Park, CA: The Henry J. Kaiser Family Foundation.
  • Kates, J., & Levi, J. (2007). Insurance coverage and access to HIV testing and treatment: Considerations for individuals at risk for infection and for those with undiagnosed infection. Clinical Infectious Diseases, 45(Suppl. 4), S255–260. doi:10.1086/522547
  • Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., … Moore, R. D. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 360(18), 1815–1826. doi:10.1056/NEJMoa0807252
  • Landon, B. E., Schneider, E. C., Normand, S. L., Scholle, S. H., Pawlson, L. G., & Epstein, A. M. (2007). Quality of care in Medicaid managed care and commercial health plans. JAMA: The Journal of the American Medical Association, 298(14), 1674–1681. doi:10.1001/jama.298.14.1674
  • Morin, S. F., Sengupta, S., Cozen, M., Richards, T. A., Shriver, M. D., Palacio, H., & Kahn, J. G. (2002). Responding to racial and ethnic disparities in use of HIV drugs: Analysis of state policies. Public Health Reports, 117(3), 263–272; discussion 231–262.
  • Palacio, H., Kahn, J. G., Richards, T. A., & Morin, S. F. (2002). Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: A review of the literature. Public Health Reports, 117(3), 233–251; discussion 231–232. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1497431/
  • Panel on Antiretroviral Guidelines for Adults and Adolescents. (March 27, 2012). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
  • Priest, J. L., Cantrell, C. R., Fincham, J., Cook, C. L., & Burch, S. P. (2011). Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: An evaluation of medication and health care use and costs. Population Health Management, 14(1), 43–54. doi:10.1089/pop.2010.0019
  • Shechter, S. M., Bailey, M. D., Schaefer, A. J., & Roberts, M. S. (2008). The optimal time to initiate HIV therapy under ordered health states. Operations Research, 56, 20–33. doi:10.1287/opre.1070.0480
  • Sterne, J. A., May, M., Costagliola, D., de Wolf, F., Phillips, A. N., Harris, R., … Cole, S. R. (2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies. The Lancet, 373(9672), 1352–1363. doi:10.1016/S0140-6736(09)60612-7
  • The Henry J. Kaiser Family Foundation. (2009). Fact sheet: Medicaid and HIV/AIDS. Retrieved from http://www.kff.org/hivaids/7172.cfm
  • Writing Committee for the CASCADE Collaboration. (2011). Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Archives of Internal Medicine, 171(17), 1560–1569. doi:10.1001/archinternmed.2011.401
  • Zhang, J. X., Huang, E. S., Drum, M. L., Kirchhoff, A. C., Schlichting, J. A., Schaefer, C. T., … Chin, M. H. (2009). Insurance status and quality of diabetes care in community health centers. American Journal of Public Health, 99(4), 742–747. doi:10.2105/AJPH.2007.125534

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.